S'abonner

Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis - 06/12/18

Doi : 10.1016/j.jaci.2018.03.015 
Francesca R. Santoni de Sio, PhD a, , Laura Passerini, PhD a, Silvia Restelli, BSc a, Maria Maddalena Valente, PhD a, Aleksandar Pramov, PhD b, Maria Elena Maccari, MD c, Francesca Sanvito, MD d, Maria Grazia Roncarolo, MD, PhD e, f, Matthew Porteus, MD, PhD e, f, Rosa Bacchetta, MD a, e,
a San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy 
d Division of Pathology, IRCCS San Raffaele Scientific Institute, Milan, Italy 
b University Center for Statistics in the Biomedical Sciences (CUSSB), San Raffaele Vita–Salute University, Milan, Italy 
c School of Medicine, San Raffaele Vita–Salute University, Milan, Italy 
e Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford School of Medicine, Stanford, Calif 
f Institute of Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, Calif 

Corresponding authors: Francesca R. Santoni de Sio, PhD, via Olgettina 58, 20132 Milan, Italy.via Olgettina 58Milan20132Italy∗∗Rosa Bacchetta, MD, Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, 265 Campus Dr, Lokey Stem Cell Building, G3015, Stanford, CA 94305.Division of Stem Cell Transplantation and Regenerative MedicineDepartment of Pediatrics265 Campus DrLokey Stem Cell Building, G3015StanfordCA94305

Abstract

Background

Forkhead box P3 (FOXP3) is a key transcription factor in regulatory T (Treg) cell function. FOXP3 gene mutations cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, a fatal autoimmune syndrome. FOXP3 has also been proposed to act in effector T (Teff) cells, but to date, this role has not been confirmed.

Objective

We sought to evaluate the effect of reduced FOXP3 expression on human Treg and Teff cell development and correlate it with IPEX syndrome immune pathology.

Methods

We developed a model of humanized mice (huMice) in which the human hematopoietic system is stably knocked down or knocked out for the FOXP3 gene (knockdown [KD]/knockout [KO] huMice).

Results

Because FOXP3-KD/KO was not 100% effective, residual FOXP3 expression in hematopoietic stem progenitor cells was sufficient to give rise to Treg cells with normal expression of FOXP3. However, numerous defects appeared in the Teff cell compartment. Compared with control mice, FOXP3-KD/KO huMice showed altered thymocyte differentiation, with KD/KO thymocytes displaying significantly reduced T-cell receptor (TCR) signaling strength and increased TCR repertoire diversity. Peripheral KD/KO Teff cells were expanded and showed signs of homeostatic proliferation, such as a significantly contracted TCR repertoire, a severely reduced naive compartment, decreased telomeric repeat-binding factor 2 expression, and a skew toward a TH2 profile, resembling an aged immune system. Consistent with results in FOXP3-KD/KO huMice, analysis of patients with IPEX syndrome provided evidence of defects in the Teff cell compartment at both the thymic and peripheral levels.

Conclusions

These findings support an intrinsic role for human FOXP3 in controlling thymocyte maturation and peripheral expansion of Teff cells and reveal a previously undescribed pathogenic mechanism through an altered Teff cell compartment in patients with IPEX syndrome.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : Forkhead box P3, effector T cells, regulatory T cells, immune tolerance, humanized mice, T-cell differentiation, immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, autoimmunity

Abbreviations used : APC, APECED, BM, ddPCR, FOXP3, HD, GAPDH, GFP, HPRT, HSPC, huMice, IPEX, KD, KO, LV, NHEJ, NPC, NSG, PB, PE, PerCP, shRNA, TALEN, TCR, Teff, TERF2, TREC, Treg, TSDR, TSS


Plan


 Supported by Telethon (Tele10-A4 to R.B.), Seventh Framework Project of the European Community (CellPID to R.B.), NIH-R21 (AI123896-01A1 to R.B.), and the Italian Ministry of Health (GR-2010-2317550 to F.R.S.d.S.).
 Disclosure of potential conflict of interest: M. Porteus reports personal fees and other from CRISPR Tx outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.


© 2018  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 142 - N° 6

P. 1909 - décembre 2018 Retour au numéro
Article précédent Article précédent
  • Mast cells regulate CD4+ T-cell differentiation in the absence of antigen presentation
  • Hector Rodriguez Cetina Biefer, Timm Heinbokel, Hirofumi Uehara, Virginia Camacho, Koichiro Minami, Yeqi Nian, Suresh Koduru, Rachid El Fatimy, Ionita Ghiran, Alexander J. Trachtenberg, Miguel A. de la Fuente, Haruhito Azuma, Omid Akbari, Stefan G. Tullius, Anju Vasudevan, Abdallah Elkhal
| Article suivant Article suivant
  • Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency
  • Ann Gardulf, Hassan Abolhassani, Rolf Gustafson, Lars E. Eriksson, Lennart Hammarström

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.